Laboratory studies have found that a combination of THC and CBD can kill ovarian cancer cells without harming healthy cells. Researchers are exploring whether future cancer treatments could be ...
Overcoming acquired treatment resistance is one of the major challenges in the fight against cancer. While combination ...
The Maria star, 50, candidly revealed why she's chosen to show the results of her preventive double mastectomyfrom over a ...
Ovarian cancer, often a \"silent killer,\" is the 8th most common cancer in women globally and the third in India. Early ...
Uniogen's progress toward clinical commercialization aligns with larger internal goals of bringing cancer diagnostics to market, with a specific focus on women's health.
Morning Overview on MSNOpinion
Promising cancer blood test masks a critical weakness
Blood tests that promise to spot cancer before symptoms appear are racing toward clinics, pitched as a simple vial of blood ...
1 Department of Gynaecology, University Hospitals of Coventry and Warwickshire, Coventry, UK. 2 Department of Gynaecology, University Hospitals of Leicester, Leicester, UK. 3 Department of ...
The tests have not been approved by federal regulators, but that hasn’t stopped patients from wanting them — and doctors from worrying. By Nina Agrawal In the spring of 2021, the cancer field was ...
CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, announced today that the U.S. Food and Drug Administration (FDA) has approved the ...
IsoPSA, a blood-based test, aids in diagnosing high-grade prostate cancer by analyzing PSA protein structural variants. FDA approval was based on a large-scale, prospective study and other validation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results